-
Mashup Score: 61Online Event - 6 month(s) ago
Phosphorylated tau (p-Tau), amyloid-beta (Ab) 42/40, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL) are current key Alzheimer’s disease (AD) blood-based b iomarkers. Interpreting results of the four biomarkers simultaneously in a clinical context is challenging due to issues such as tissue sample size, cost, and timing. A decision algorithm could aid in the interpretation, tailored to clinically relevant questions: 1) identify positive amyloid status among preclinical and prodromal
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 15Online Event - 6 month(s) ago
Over the past 20 years, researchers have developed and helped commercialize blood tests for Alzheimer’s disease (AD). Yet only half of patients with neurodegenerative diseases end up with an AD diagnosis. For the rest, no tests are available to determine which underlying disease is responsible for failing memory or other cognitive issues. Previous attempts to develop biomarkers for other types of dementia, such as frontotemperal dementia or Lewy body dementia, have been unsuccessful. This is likely
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet-
Join #ScienceWebinars for their next #Technology broadcast on Thursday, 2 November at 12 p.m. ET ➡️ Improving diagnostics for #Alzheimers and other neurodegenerative diseases. Register today: https://t.co/r5NlTrqOyY #Webinar https://t.co/B52WOD1ZJR
-
-
Mashup Score: 11Online Event - 7 month(s) ago
Precision medici ne is critically dependent on accurate methods for diagnosing and staging disease, and predicting drug response. Immunohistochemistry using antibodies to immunostain tissue remains the gold standard diagnostic method in cancer pathology laboratories. However, recently methods using immunofluorescence (IF) have evolved to enable highly multiplexed tissue imaging, which promises to enhance research studies and clinical practice with precise, spatially resolved single-cell data. While the
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet-
Join #ScienceWebinars for their next #Technology broadcast on Wednesday, 25 October at 12 p.m. ET ➡️ Innovations in #Immunofluorescence: What’s new and what’s essential. Register today: https://t.co/ltWaS6F7Ia #Webinar https://t.co/sYY7Lss0Hu
-
-
Mashup Score: 0Online Event - 7 month(s) ago
Mental health is a vast and growing worldwide problem. Roughly 1 in 5 American adults suffers from a mental health condition, according to the U.S. Centers for Disease Control and Prevention. Those with firsthand experience or a loved one who is suffering know the significant social and economic impact it can have on everyday life. Because these conditions often affect people at a young age, they will need treatment for many years, during which they might not be able to participate in society to their
Source: view6.workcast.netCategories: General Medicine News, Future of MedicineTweet-
Join #ScienceWebinars for their next #Technology broadcast on Monday, 23 October at 12 p.m. ET ➡️ #AI in #MentalHealth: Opportunities and challenges. Register today: https://t.co/FG4Sbz31sP #Webinar https://t.co/awuT6LmHeO
-
-
Mashup Score: 0Online Event - 7 month(s) ago
Blood fats are key biomarkers for heart, liver, and other diseases, highlighting the importance of lipid metabolism for health. Lipoprotein lipase (LPL) is a key enzyme involved in hydrolyzing triglycerides from circulating lipoproteins in the blood, releasing free fatty acids. Understanding the structural and functional aspects of LPL is crucial, given its significant role in lipid metabolism and related diseases. In this webinar, the speaker will describe experiments that uncovered how LPL interacts
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars for their next #Technology broadcast on Wednesday, 18 October at 12 p.m ET ➡️ A fresh look at fat metabolism: Studying lipoprotein lipase oligomerization dynamics with #cryoEM and mass photometry. Register today: https://t.co/URiw43ct6F https://t.co/Ohxjtjs5Sp
-
-
Mashup Score: 0Online Event - 8 month(s) ago
Measurable residual disease, or MRD (also know n as minimal residual disease), refers to detectable cancer cells that remain in cancer patients after treatment. Even small numbers of these cells, particularly in blood cancers—such as leukemia, lymphoma, or multiple myeloma—may replicate and cause relapse, but unfortunately these rare cells usually can’t be detected by microscopy. Newer, more sensitive assays—such as next-generation sequencing (NGS) and digital PCR (dPCR)—can quantify MRD more precisely,
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars for their next #Technology broadcast on Wednesday, 20 September at 12 p.m. ET: Emerging technologies for the detection of measurable residual disease (MRD): NGS and dPCR. Register today: https://t.co/DTjuWdvRhY #Webinars https://t.co/KVvv2W5ytv
-
-
Mashup Score: 2Online Event - 8 month(s) ago
Advocacy in rare disease is complex and challenging, but there are effective methods that advocates can use to communicate with the public. In this panel discussion, experts in communication, public relations, and influencing will discuss strategies and tactics to advance advocacy for rare disease. The discussion will explore how advocates can: Raise awareness on how rare disease impacts individuals and families through social media, events, press releases, storytelling, and community engagement, and by
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
On 8 June 2023, #ScienceWebinars hosted a #technology broadcast ➡️ Advocacy in rare disease: Crafting the public narrative. Did you miss it? Catch it here: https://t.co/AWjtYyJTeL #webinar https://t.co/9Y369LnX8Y
-
-
Mashup Score: 2Online Event - 9 month(s) ago
Across the globe, regulatory landscapes are notoriously complex and difficult to navigate, yet laws regarding human health can literally be a matter of life and death. Diagnosis and treatment remain challenging for the more than 7,000 rare diseases impacting 350 million people worldwide. Policy makers set research funding agendas and make laws, such as the Orphan Drug Act, that can tip the balance on whether drug makers will pursue treatments for rare disease and make them accessible. Advocates play a
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars for their next #technology broadcast on Thursday, 31 August at 12 p.m. ET ➡️ Advocacy in rare disease: Working the regulatory angle Register today: https://t.co/vrcEuCfp7E #webinar https://t.co/jyGPtxb108
-
-
Mashup Score: 5Online Event - 9 month(s) ago
The immune system is the body’s premier line of defense against microbial pathogens, yet some microbes are treated as friends instead of foes. The colonization of the human body with microbes is critical to a newborn’s developing immune system and metabolic health, and this dynamic process may impact long-term health as well. Researchers are exploring how the body’s earliest interactions with the mic robiome can misfire, leading to childhood disease. Others are probing the molecular details of how immune
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars for their next #technology broadcast on Wednesday, 23 August at 12 p.m. ET ➡️ Learning to coexist: How the interplay between the #microbiome and the immune system impacts human health. Register today: https://t.co/SrckeuxrvE #webinar https://t.co/5AScoQwmD6
-
-
Mashup Score: 2Online Event - 9 month(s) ago
The immune system is the body’s premier line of defense against microbial pathogens, yet some microbes are treated as friends instead of foes. The colonization of the human body with microbes is critical to a newborn’s developing immune system and metabolic health, and this dynamic process may impact long-term health as well. Researchers are exploring how the body’s earliest interactions with the mic robiome can misfire, leading to childhood disease. Others are probing the molecular details of how immune
Source: view6.workcast.netCategories: Future of Medicine, Latest HeadlinesTweet-
Join #ScienceWebinars for their next #technology broadcast on Wednesday, 23 August at 12 p.m. ET ➡️ Learning to coexist: How the interplay between the #microbiome and the immune system impacts human health. Register today: https://t.co/j12XuVm7NQ #webinar https://t.co/o6cTtpcU96
-
Join #ScienceWebinars for their next #Technology broadcast on Wednesday, 8 November at 12 p.m. ET ➡️ Advancing #Alzheimers Disease detection through blood-based biomarkers. Register today: https://t.co/alMballdCl https://t.co/8hYYKkCZRn